Literature DB >> 27688157

Clinical spectrum and diagnostic pitfalls of multiple abnormal uptakes on bone scintigraphy.

Fumihiro Tsubaki1, Seiji Kurata2, Shuji Nagata1, Kiminori Fujimoto1, Toshi Abe1.   

Abstract

Bone scintigraphy with technetium-99m (99mTc)-labeled diphosphonates is one of the most frequently performed radionuclide procedures. Accumulation of 99mTc-labeled diphosphonate is well recognized to reflect conditions of accelerated bone turnover and metabolism. Therefore, it is a functional imaging modality for detecting metastatic bone tumors, metabolic bone disease, traumatic injury, and inflammation. This pictorial essay describes the possible patterns of distribution of abnormal uptake for differential diagnosis of metastatic bone tumor, as well as the diagnostic pitfalls of bone scintigraphy.

Entities:  

Keywords:  Bone scintigraphy; Metabolic disorder; Metastatic disease

Mesh:

Substances:

Year:  2016        PMID: 27688157     DOI: 10.1007/s11604-016-0585-8

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  13 in total

Review 1.  Mechanisms of bone metastasis.

Authors:  G David Roodman
Journal:  N Engl J Med       Date:  2004-04-15       Impact factor: 91.245

Review 2.  The role of single photon emission computed tomography in bone scintigraphy.

Authors:  I P Murray; J Dixon
Journal:  Skeletal Radiol       Date:  1989       Impact factor: 2.199

Review 3.  Radionuclide bone imaging: an illustrative review.

Authors:  Charito Love; Anabella S Din; Maria B Tomas; Tomy P Kalapparambath; Christopher J Palestro
Journal:  Radiographics       Date:  2003 Mar-Apr       Impact factor: 5.333

4.  Intertrabecular pattern of tumors metastatic to bone.

Authors:  T Yamaguchi; K Tamai; M Yamato; K Honma; Y Ueda; K Saotome
Journal:  Cancer       Date:  1996-10-01       Impact factor: 6.860

Review 5.  Bone scintigraphy in metabolic bone disease.

Authors:  P J Ryan; I Fogelman
Journal:  Semin Nucl Med       Date:  1997-07       Impact factor: 4.446

6.  Brown tumors mimicking bone metastases.

Authors:  Nezih Meydan; Sabri Barutca; Engin Guney; Sukru Boylu; Oner Savk; Nil Culhaci; Mediha Ayhan
Journal:  J Natl Med Assoc       Date:  2006-06       Impact factor: 1.798

Review 7.  Bone scintigraphy: Part 3. Bone scanning in metabolic bone disease.

Authors:  I Fogelman; B D Collier; M L Brown
Journal:  J Nucl Med       Date:  1993-12       Impact factor: 10.057

Review 8.  Bone scintigraphy: Part 2. Orthopedic bone scanning.

Authors:  B D Collier; I Fogelman; M L Brown
Journal:  J Nucl Med       Date:  1993-12       Impact factor: 10.057

Review 9.  Radionuclide imaging of inflammation and infection in the acute care setting.

Authors:  Charito Love; Christopher J Palestro
Journal:  Semin Nucl Med       Date:  2013-03       Impact factor: 4.446

Review 10.  Miscellaneous indications in bone scintigraphy: metabolic bone diseases and malignant bone tumors.

Authors:  Gary J R Cook; Gopinath Gnanasegaran; Sue Chua
Journal:  Semin Nucl Med       Date:  2010-01       Impact factor: 4.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.